Skip to content
  • Sunday, 26 July 2026
  • 6:54 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Novel Combination Therapy CagriSema Demonstrates Promising Results in Obesity Management with Preserved Muscle Strength
Pharmaceutical R&D

Novel Combination Therapy CagriSema Demonstrates Promising Results in Obesity Management with Preserved Muscle Strength

Teuku Ryan May 13, 2026 0

On 12 May 2026, at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye, groundbreaking findings from the Phase…

Read More
Clinical Diagnostics & Pathology

Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs

Reynand Amr Wu May 13, 2026 0

A recent population-based study, published in CANCER, a journal of the American Cancer Society, has issued a significant alert to…

Read More
Biotech & Genetic Research

Novel Stem Cell Therapy Protocol Shows Significant Promise for Type 1 Diabetes Treatment, Reversing Disease in Mice.

Jia Lissa May 12, 2026 0

Scientists at the forefront of regenerative medicine, based at the esteemed Karolinska Institutet and KTH Royal Institute of Technology in…

Read More
Laboratory Automation & Robotics

Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior

Lana Keisha May 12, 2026 0

Cellular Intelligence, a burgeoning biotech startup, has announced the acquisition of global rights to a clinical-stage Parkinson’s disease cell therapy,…

Read More
Pharmaceutical R&D

Cellular Intelligence Licenses Novo Nordisk’s Parkinson’s Cell Therapy Program Following Company’s Strategic Pivot

Teuku Ryan May 11, 2026 0

Seven months after Danish pharmaceutical giant Novo Nordisk officially shuttered its dedicated cell therapy unit in October 2025, a significant…

Read More
Stem Cell & Regenerative Medicine

Ludwig Cancer Research Study Reveals Novel Combination Therapy for Acute Myelogenous Leukemia Targeting Epigenetic Barriers to Cell Differentiation

Dwi Wanna May 10, 2026 0

A collaborative international study led by researchers at Ludwig Cancer Research has identified a breakthrough therapeutic strategy for acute myelogenous…

Read More
Pharmaceutical R&D

Novartis Breaks Ground on New Radioligand Therapy Manufacturing Facility in Denton, Texas, Bolstering US Healthcare Infrastructure

Teuku Ryan May 9, 2026 0

Novartis has commenced construction on a significant new radioligand therapy (RLT) manufacturing facility in Denton, Texas, a pivotal development in…

Read More
Pharmaceutical R&D

GSK Secures Promising Metabolic Oligonucleotide Therapy Rights from SiranBio in Up to $1 Billion Deal

Teuku Ryan May 7, 2026 0

In a significant move to bolster its pipeline and solidify its strategic focus on the complex challenges of obesity, global…

Read More
Clinical Diagnostics & Pathology

Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs

Reynand Amr Wu May 6, 2026 0

A recent population-based study, published in CANCER, a prestigious journal of the American Cancer Society, has brought to light a…

Read More
Pharmaceutical R&D

The Shifting Landscape of Gene Therapy: Non-Viral Approaches Emerge as Promising Alternatives

Teuku Ryan May 6, 2026 0

Cell and gene therapies (CGTs) have long been heralded for their potential to revolutionize the treatment of complex and previously…

Read More

Posts pagination

1 … 4 5 6 … 9
Retatrutide eases sleep apnea and knee arthritis in new Phase 3 data, extending Lilly’s obesity lead over NovoGinkgo, Tangible and Inductive Bio Launch ADME-One Platform to Revolutionize Early Drug Discovery Decisions with AI and AutomationNew Research Challenges the Foundations of Time and Memory through the Lens of the Boltzmann Brain HypothesisInternational Research Team Discovers First Isospin-Symmetric Island of Inversion in Molybdenum-84
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ